Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis-Reference-Cited by-同舟云学术

Critical observations on neuroblastoma treatment with 131-I-metaiodobenzylguanidine at diagnosis

Published:1993 Issue:6 Volume:21 Page:411-415
ISSN:0098-1532
Container-title:Medical and Pediatric Oncology
language:en
Short-container-title:Med. Pediatr. Oncol.

Author:

Mastrangelo Renato,Lasorella Anna,Iavarone Antonio,Rufini Vittoria,Troncone Luigi,Danza Francesco,Riccardi Riccardo

Publisher

Wiley

Subject

Cancer Research,Oncology,Pediatrics, Perinatology, and Child Health

Reference17 articles.

1. The treatment of neuroblastoma.

2. , , et al.: High dose chemotherapy with BMT as consolidation treatment in neuroblastoma. The LMCE unselected group of patients revisited with a median follow up of 55 months after BMT. Proceedings of Fifth Symposium on Neuroblastoma Research, Philadelphia, 1990.

3. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction Regimen in High-Risk Neuroblastoma: A Pilot Study of Highly Effective Continuous Exposure of Tumor Cells to Radio-Chemotherapy Sequence for 1 Month. The Critical Role of Iodine-131-Metaiodobenzylguanidine;Cancers;2022-10-21

2. Neuroblastoma;Clinical Nuclear Medicine in Pediatrics;2016

3. [131I]Metaiodobenzylguanidine therapy in neural crest tumors;Nuclear Medicine Communications;2011-12

4. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy;British Journal of Cancer;2001

5. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients;British Journal of Cancer;1999-11-26